New topical treatments for atopic dermatitis: Active comparators are needed

Affiliations

Editorial

Hywel C Williams. J Am Acad Dermatol. 2021 Oct.

. 2021 Oct;85(4):1065-1066.

doi: 10.1016/j.jaad.2021.06.002. Epub 2021 Jun 18.

¹ Centre of Evidence-Based Dermatology at the University of Nottingham, Nottingham, United Kingdom. Electronic address: Hywel.williams@nottingham.ac.uk.

No abstract available

Keywords: Atopic dermatitis; atopic eczema; clinical trials; comparative effectiveness research; eczema.

Conflict of interest statement

Conflicts of interest None disclosed.

Efficacy and safety of ruxolitinib cream for the treatment of atopic dermatitis: Results from 2 phase 3, randomized, double-blind studies.
Papp K, Szepietowski JC, Kircik L, Toth D, Eichenfield LF, Leung DYM, Forman SB, Venturanza ME, Sun K, Kuligowski ME, Simpson EL. Papp K, et al. J Am Acad Dermatol. 2021 Oct;85(4):863-872. doi: 10.1016/j.jaad.2021.04.085. Epub 2021 May 4. J Am Acad Dermatol. 2021. PMID: 33957195 Clinical Trial.